LP411324-9
Nor-W-18+Nor-W-15
Active
Description
W-18 (4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2-piperidinylidene]-benzenesulfonamide) and W-15 (4-chloro-N-[1-(2-phenylethyl)-2-piperidinylidene]-benzenesulfonamide) are emerging drugs of abuse. Although they have not been shown to have specific opioid receptor activity PMID: 29202454, they are structurally related to the opioid agonist fentanyl. W-18 and W-15 are 2 of a series of substances (named W-1 through W-32) that were synthesized in the 1980s as possible analgesics. W-19 is another similar compound that classified as an emerging drug of abuse. At the time of this writing the literature is unclear about the potency of these compounds and their dealkylation metabolites, nor-W-18, nor-W-15 and nor-W-19. Source: Regenstrief LOINC
Basic Part Properties
- Part Display Name
- Nor-W-18+Nor-W-15
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2019-08-21
- Construct for LOINC Short Name
- Nor-W-18+Nor-W-15
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP411324-9
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | Nor-W-18+Nor-W-15 |
| it-IT | Italian (Italy) | Nor-W-18+Nor-W-15 |
| es-ES | Spanish (Spain) | Nor-W-18+Nor-W-15 |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright